Pilot Study of Decitabine and Haplo-identical Natural Killer Cells in Acute Myeloid Leukemia (AML)

Trial Profile

Pilot Study of Decitabine and Haplo-identical Natural Killer Cells in Acute Myeloid Leukemia (AML)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Aldesleukin (Primary) ; Decitabine (Primary) ; Natural killer cell therapy (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2016 Status changed from suspended to recruiting.
    • 17 Jan 2016 Status changed from recruiting to suspended, as reported by ClinicalTrials.gov.
    • 12 May 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top